Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | -104.8 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | -104.8 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | | | |
| Selling, general and administrative | 32.9 | 4.9 | 1.2 | |
| Research and development | 51.9 | 13.3 | 8.4 | 5.9 |
| General and administrative | | | | 1.7 |
| EBIT | -189.5 | -18.2 | -9.6 | -7.7 |
| EBIT margin | 180.9% | | | |
| Pre-tax income | -173.1 | -18.3 | -9.6 | -7.7 |
| Income taxes | 0.9 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | 0.0% |
| Net income | -174.0 | -18.3 | -9.6 | -7.7 |
| Net margin | 166.1% | | | |
| |
| Diluted EPS | ($0.68) | ($0.08) | ($0.04) | |
| Shares outstanding (diluted) | 254.1 | 220.0 | 220.0 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|